Report Code: A13382 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Doxycycline is an antibacterial drug is derived from oxytetracycline and is available as doxycycline hyclate. Doxycycline hyclate is used in the treatment of many bacterial infections such as acne, urinary tract infection, intestinal infections, respiratory infections, eye infections, gonorrhea, syphilis, and others. Moreover, these drugs can be used to treat blemishes and bums caused by rosacea. Generally doxycycline hyclate is not prescribed to lactating & breastfeeding patients. Doxycycline hyclate is also not prescribed to children below 8 years because of it can cause permanent yellowing of their teeth unless it is a life threatening condition such as anthrax.
COVID-19 Impact Analysis
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the oral doxycycline hyclate market.
Top Impacting Factors
Market Trends
New Product Launches to Flourish the Market
In 2020, Alembic Pharma announced U.S. FDA permission launch of generic doxycycline hyclate tablets. This product is generic version of Almirall tablet. This tablet can be used in treatment of bacterial infection.
In 2018, Lupin announced launch of doxycycline hyclate tablet USP 100 mg in U.S. Company received U.S. FDA approval for launch of tablet and this tablet used in treatment of acne & bacterial infections.
Key Benefits of the Report
Questions Answered in the Oral Doxycycline Hyclate Market Report
Oral Doxycycline Hyclate Market Report Highlights
Aspects | Details |
---|---|
By Product Type |
|
By Application |
|
By Distribution Channel |
|
By Region |
|
Key Market Players | Almirall, Novel Laboratories, Alembic Pharmaceuticals, Prinston Pharmaceutical, Zydus Pharmaceuticals, Emcure, Mylan, G&W Laboratories, Amneal Pharmaceuticals, Ajanta Pharma, Heritage Pharmaceuticals, Par Pharmaceutical, Sun Pharmaceutical, Teva, Mayne Pharma |
Loading Table Of Content...
Start reading.
This Report and over 71,295+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time for readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save the time of readers